Philips Announces Plan for More Than USD 150 Million of New Investment in Manufacturing and R&D in the U.S. to Expand Production of AI-powered Health Technology Innovations

Global health technology leader, which serves 90% of U.S. hospitals, builds on top of existing U.S. investments to support local manufacturing and more than USD 900 million of annual R&D investment in the U.S. CAMBRIDGE, Mass.–(BUSINESS WIRE)–Philips, a global leader in health technology, today announced a plan for new investments of more than USD 150 … [Read more…]

Denmark Pharmaceutical Market Research Report 2025-2033 | High R&D Investment, Academic-Healthcare Collaboration, and Supportive Regulations Fuel Expansion – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Denmark Pharmaceutical Market – Drug Development & Forecast 2025-2033” report has been added to ResearchAndMarkets.com’s offering. Denmark Pharmaceutical Market is expected to reach US$ 5.20 billion by 2033 from US$ 3.81 billion in 2024, with a CAGR of 3.52% from 2025 to 2033. Heavy R&D spending, government assistance, well-developed healthcare system, aging population, … [Read more…]

Hy-Vee Health and Oscar Serve Up a New Era of Employer Healthcare

NEW YORK & DES MOINES, Iowa–(BUSINESS WIRE)–Oscar Health, Inc. (NYSE: OSCR), a leading healthcare technology company in the individual market, and Hy-Vee, Inc., America’s No. 1 grocery store based in the Midwest, are teaming up to introduce a one-of-a-kind healthcare benefit. The landmark health insurance plan saves employers money and gives employees concierge care at … [Read more…]

Afya Limited Announces Second-Quarter and First-Half 2025 Financial Results

Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed BELO HORIZONTE, Brazil–(BUSINESS WIRE)–Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, … [Read more…]

HeartBeam Reports Second Quarter 2025 Results

Executing on Commercial Readiness Plans in Anticipation of FDA 510(k) Clearance for Groundbreaking 12-lead Electrocardiogram (ECG) Synthesis Software Engaged in Ongoing Productive Discussions with FDA Related to the 510(k) Application Increased Business Development Resources to Match Inbound Interest from Industry Partners Management to Host Webcast and Conference Call Today at 4:30 p.m. ET SANTA CLARA, … [Read more…]

Flatiron Health Announces Research to Be Presented at IASLC 2025 World Conference on Lung Cancer Hosted by the International Association for the Study of Lung Cancer

Flatiron’s 2025 WCLC research showcases the power of multimodal real-world oncology data and innovative AI-data extraction methodologies to generate actionable evidence for people with lung cancer NEW YORK–(BUSINESS WIRE)–Flatiron Health today announced eight abstracts leveraging its high-quality multimodal data have been accepted for poster presentation and e-Poster presentation at the IASLC 2025 World Conference on … [Read more…]

CheckedUp Named to Inc. 5000 List of America’s Fastest-Growing Companies for 4th Time, with Three-Year Revenue Growth of 268%!

NEW YORK–(BUSINESS WIRE)–CheckedUp, the fastest-growing digital Point of Care company transforming patient and provider engagement, today announced its fourth appearance on the 2025 Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list provides a data-driven snapshot of the most successful companies within the economy’s most dynamic segment—its independent, … [Read more…]

Wenzel Spine Announces Limited U.S. Commercial Launch and First Cases of its Expandable panaSIa™ SI Fusion System

AUSTIN, Texas–(BUSINESS WIRE)–Wenzel Spine, Inc., a medical device company pioneering minimally invasive surgical and analytic solutions for spinal disorders, today announced completion of first cases and the U.S. limited commercial launch of its novel panaSIa™ Expandable SI Fusion System. panaSIa is the first expandable sacroiliac (SI) fusion implant cleared by the FDA and represents a … [Read more…]